Literature DB >> 630531

Effect of 5-fluorouracil on liver regeneration and metabolism after partial hepatectomy in the rat.

N Nagasue, M Kobayashi, A Iwaki, H Yukaya, R Kanashima, K Inokughi.   

Abstract

The effects of 5-fluorouracil (5-FU) on regenerating liver were studied after two thirds hepatectomy in rats. In Group I, 68% hepatectomy was performed. In Group II, 5-FU in a dose of 20 mg/kg was administered intravenously immediately after, 24 and 48 hours after the same hepatectomy. In Group III, the same amount of 5-FU was given after sham-operation. The mortality rates were 4.5% in Group I, 28.0% in Group II, and 0% in Group III. The treatment with 5-FU following hepatectomy caused not only suppression but delay of liver cell division. Histologic changes such as cellular degeneration, liver steatosis and dilatation of the sinusoidal space were marked and prolonged in the hepatectomy-5-FU group. The metabolic abnormalities in albumin, cholesterol, triglycedides, and phospholipids were further more profound in Group II compared to those in Group I. In Group III, moderate derangements in albumin, triglycerides and phospholipids were observed. The results may indicate that adjuvant chemotherapy with 5-FU or similar drugs immediately after partial hepatectomy in hepatoma patients should be performed with great care if necessary. Otherwise, it should not be carried out until hepatic regneration is almost completed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630531     DOI: 10.1002/1097-0142(197802)41:2<435::aid-cncr2820410209>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.

Authors:  Mehdi Karoui; Christophe Penna; Mohamed Amin-Hashem; Emmanuel Mitry; Stephane Benoist; Brigitte Franc; Philippe Rougier; Bernard Nordlinger
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis.

Authors:  N Nagasue; H Yukaya; Y Ogawa; H Kohno; T Nakamura
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

3.  Effects of postoperative adjuvant chemotherapy on liver regeneration in partially hepatectomized rats.

Authors:  H Kohno; K Inokuchi
Journal:  Jpn J Surg       Date:  1984-11

4.  Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma.

Authors:  Y Sasaki; S Imaoka; M Fujita; Y Miyoshi; H Ohigashi; O Ishikawa; H Furukawa; H Koyama; T Iwanaga; H Kasugai
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

5.  Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases.

Authors:  Kuniya Tanaka; Takafumi Kumamoto; Ryusei Matsuyama; Kazuhisa Takeda; Yasuhiko Nagano; Itaru Endo
Journal:  J Gastrointest Surg       Date:  2009-11-03       Impact factor: 3.452

6.  Influence of vinyl chloride monomer (VCM) and As2O3 on rat liver cell proliferation after partial hepatectomy.

Authors:  K Norpoth; D Gottschalk; I Gottschalk; U Witting; H Thomas; D Eichner; E H Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

7.  Liver regeneration and tumor growth in the rat after partial hepatectomy.

Authors:  H Ichihashi; H Mabuchi; M Suenaga; T Kondo
Journal:  Jpn J Surg       Date:  1984-11

8.  Identification and location of label retaining cells in mouse liver.

Authors:  Fusheng Li; Leilei Lu; Jingjing Lu
Journal:  J Gastroenterol       Date:  2009-10-03       Impact factor: 7.527

9.  Promotion of hepatic metastases by liver resection in the rat.

Authors:  J Mizutani; T Hiraoka; R Yamashita; Y Miyauchi
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.

Authors:  Alexander A Parikh; Bernhard Gentner; Tsung-Teh Wu; Steven A Curley; Lee M Ellis; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.